2020
DOI: 10.1002/ange.202002341
|View full text |Cite
|
Sign up to set email alerts
|

Transition‐Metal‐Free Carbon Isotope Exchange of Phenyl Acetic Acids

Abstract: A transition‐metal‐free carbon isotope exchange procedure on phenyl acetic acids is described. Utilizing the universal precursor CO2, this protocol allows the carbon isotope to be inserted into the carboxylic acid position, with no need of precursor synthesis. This procedure enabled the labeling of 15 pharmaceuticals and was compatible with carbon isotopes [14C] and [13C]. A proof of concept with [11C] was also obtained with low molar activity valuable for distribution studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
16
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 75 publications
(60 reference statements)
0
16
0
Order By: Relevance
“…C(sp 3 ) acids that form stabilized carbanions upon ionic decarboxylation can undergo exchange with CO2 spontaneously at high temperatures in the solid state 29 or in solution. [30][31][32].In contrast, compounds that lack strong anion stabilizing groups like nitro-or cyanoaryl acetate groups require high reaction temperatures (³150 ºC), long reaction times (³24 hours), or are simply inert towards exchange. Audisio and co-workers demonstrated the 11 C-labelling of the arylacetate drugs Flurbiprofen and Tolmetin by uncatalyzed exchange with [ 11 C]CO2, although slow kinetics and harsh conditions resulted in low radiochemical yields (RCY) (7% and 3% respectively at 150 ºC).…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…C(sp 3 ) acids that form stabilized carbanions upon ionic decarboxylation can undergo exchange with CO2 spontaneously at high temperatures in the solid state 29 or in solution. [30][31][32].In contrast, compounds that lack strong anion stabilizing groups like nitro-or cyanoaryl acetate groups require high reaction temperatures (³150 ºC), long reaction times (³24 hours), or are simply inert towards exchange. Audisio and co-workers demonstrated the 11 C-labelling of the arylacetate drugs Flurbiprofen and Tolmetin by uncatalyzed exchange with [ 11 C]CO2, although slow kinetics and harsh conditions resulted in low radiochemical yields (RCY) (7% and 3% respectively at 150 ºC).…”
mentioning
confidence: 99%
“…Audisio and co-workers demonstrated the 11 C-labelling of the arylacetate drugs Flurbiprofen and Tolmetin by uncatalyzed exchange with [ 11 C]CO2, although slow kinetics and harsh conditions resulted in low radiochemical yields (RCY) (7% and 3% respectively at 150 ºC). 30 With the goal of developing a mild method for direct carboxylate exchange at rates appropriate for 11 C-labelling, we considered alternative strategies for C(sp 3 )-carboxylate bond cleavage and subsequent CO2 recapture. Here we show that a family of organic photocatalysts mediate the exchange of CO2 groups without the need for prior stoichiometric carboxylate activation or high temperatures (Fig 1B).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…14 The pioneering methods from Gauthier, 15 Baran, 16 and Cantat/Audisio 17 using 13 CO or 13 CO2, to facilitate CIE showed the power of utilizing transition metal catalysts to achieve C-C bond activation, allowing for a sustainable late-stage carbon isotope enrichment strategy for pharmaceutically relevant small molecules. Despite added progress in this arena [18][19][20][21][22] , CIE labeling approaches are limited to carboxylic acids, revealing the unmet need for new CIE methods to address the diverse functional groups present in pharmaceuticals and natural products, and ideally employing easily handleable solid labeling sources (Figure 2A). 23 Herein we report a novel CIE strategy which is the first to employ Ar-CN exchange and demonstrate its utility for incorporating 13 C or 14 C labels (Figure 2B).…”
mentioning
confidence: 99%
“…14 The pioneering methods from Gauthier, 15 Baran, 16 and Cantat/Audisio 17 using 13 CO or 13 CO2, to facilitate CIE showed the power of utilizing transition metal catalysts to achieve C-C bond activation, allowing for a sustainable late-stage carbon isotope enrichment strategy for pharmaceutically relevant small molecules. Despite added progress in this arena [18][19][20][21][22] , CIE labeling approaches are limited to carboxylic acids, revealing the unmet need for new CIE methods to address the diverse functional groups present in pharmaceuticals and natural products, and ideally employing easily handleable solid labeling sources (Figure 2A). 23 Herein we report a novel CIE strategy which is the first to employ Ar-CN exchange and demonstrate its utility for incorporating 13 C or 14 C labels ( Figure 2B).…”
mentioning
confidence: 99%